Conor Hale

Fluid Biomed has raised $27 million to move forward with the development of its bioabsorbable stent designed to divert blood away from unstable brain aneurysms.

The FDA is boosting a recall effort from Boston Scientific regarding batteries potentially underpowering a number of the company's implanted Accolade pacemakers, which may need to be replaced earlier than planned.

Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available to healthcare providers after years of development.

Dexcom has launched a generative AI platform aimed at providing personalized lifestyle tips to the users of its over-the-counter wearable glucose biosensor.

Roche has begun rolling out a new diagnostics system that aims to bring the gold-standard accuracy of mass spectrometry to the everyday clinical lab.

Amid reports of the first severe human case of bird flu in the U.S., Labcorp has launched a molecular diagnostic test for the H5N1 virus.

The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial fibrillation.

Nerve stimulation company electroCore has signed an agreement to acquire NeuroMetrix and its Quell wearable device aimed at fibromyalgia and chronic pain.

A look back at our top stories of 2024 sees them fall into two major themes: promise, and a realignment of expectations.

The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed to replace a patient's damaged artery following traumatic injuries to the arms or legs.